1. Federal Regulations Title 21.
https://www.access.data.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm
.
2. FDA. FDA product-specific recommendations for generic drug development.
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075207.htm
.
3. Samy R, Faustino PJ, Adams W, Yu L, Khan MA, Yang Y. Development and validation of an ion chromatography method for the determination of phosphate-binding of lanthanum carbonate. J Pharm Biomed Anal. April 6, 2010;51(5):1108–12.
4. FDA. Sevelamer carbonate tablets BE recommendation.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm089620.pdf
. revised 2015.
5. FDA. Cholestyramine oral powder suspension BE recommendation.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM273910.pdf
. Revised June, 2015.